Decreased expression of β1- and β 2-adrenoceptors in human diabetic artrial appendage

Cardiovascular Diabetology

Volumn 2, Issue , 2003, Pages

  Dinçer, U Deniz ^a   Güner, Şahika ^a   Tay, Aydin ^a   Arioǧlu, Ebru ^a   Taşdelen, Atilay ^b   Aşlamaci, Sait ^b   Bidasee, Keshore R ^c  

^a ANKARA UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; MESSENGER RNA; STREPTOZOCIN; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE MODEL; FEMALE; HEART ATRIUM APPENDAGE; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; STREPTOZOCIN DIABETES; TISSUE SECTION;

EID: 2942576493     PISSN: 14752840     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2840-2-6     Document Type: Article

References (24)

1. Kannel WB and McGee DL: Diabetes and cardiovascular disease: The Framingham Study JAMA 1979, 241:2035-2038.
2. Rodrigues B and McNeill JH: The diabetic heart: metabolic causes for the development of a cardiomyopathy Cardiovas Res 1992, 26:913-922.
3. Lefkowitz RJ, Rockman HA and Koch WJ: Catecholamines, cardiac beta-adrenergic receptors, and heart failure Circulation 2000, 101:1634-7.
4. Wang X and Dhalla NS: Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure Mol Cell Biochem 2000, 214:131-55.
5. Fein FS, Aronson RS, Nordin C, Miller-Green B and Sonnenblick EH: Altered myocardial response to ouabain in diabetic rats: mechanics and electro physiology J Mol Cell Cardiol 1983, 15:769-84.
6. Dinȩr ÜD, Bidasee KR, Güner S, Tay A, Özçelikay AT and Altan VM: The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts Diabetes 2001, 50:455-61.
7. Dinçer ÜD, Özçelikay AT and Yýlmaz ED: The effects of chronic L-name and L-arginine administration on beta-adrenergic responsiveness of STZ-diabetic rat atria Pharmacol Res 2000, 41:565-70.
8. Dinȩr ÜD, Onay A, Arý N, Özçelikay AT and Altan VM: The effects of diabetes on beta-adrenoceptor mediated responsiveness of human and rat atria Diabetes Res Clin Pract 1998, 40:113-22.
9. Bidasee KR, Dinçer ÜD, and Besch HR Jr: Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rat hearts Mol Pharmacol 2001, 60:1-9.
10. Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE and Feldman AM: Reduced beta 1 receptor messenger RNA abundance in the failing human heart J Clin Invest 1993, 92:2737-2745.
11. Fowler MB, Laser JA, Hopkins GL, Minobe W and Bristow MR: Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response Circulation 1986, 74:1290-302.
12. Schotten U, Filzmaier K, Borghardt B, Kulka S, Schoendube F, Schumacher C and Hanrath P: Changes of beta-adrenergic signaling in compensated human cardiac hypertrophy depend on the underlying disease Am J Physiol Heart Circ Physiol 2000, 278:H2076-83.
13. Freeman K, Lerman I, Kranias EG, Bohlmeyer T, Bristow MR, Lefkowitz RJ, Iaccarino G, Koch WJ and Leinwand LA: Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy J Clin Invest 2001, 107(8):967-74.
14. Liggett SB: Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown J Clin Invest 2001, 107:947-8.
15. Lefkowitz RJ, Rockman HA and Koch WJ: Catecholamines, cardiac beta-adrenergic receptors, and heart failure Circulation 2000, 101:1634-7.
16. Paulson DJ, Shetlar D and Light KE: Catecholamine levels in the heart, serum and adrenals of experimental diabetic rats Fed Proc 1980, 39:637.
17. Christensen NJ: Plasma norepinephrine and epinephrine in untreated diabetics during fasting and after insulin administration Diabetes 1974, 23:1-8.
18. Brodde OE, O'Hara N, Zerkowski HR and Rohm N: Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium J Cardiovasc Pharmacol 1984, 6:1184-91.
19. Kaumann AJ: Four β-AR subtypes in the mammalian heart Trends Pharmacol Sci 1997, 18:70-76.
20. Brodde OE and Michel MC: Adrenergic and muscarinic receptors in the human heart Pharmacol Rev 1999, 51:651-90.
21. Rodefeld MD, Beau SL, Schuessler RB, Boineau JP and Saffitz JE: Beta adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: Identification of a high beta 2-adrenergic receptor density J Cardiovasc Electrophysiol 1996, 7:1039-1049.
22. Gauthier C, Tavernier G, Charpentier F, Langin D and Le Marec H: Functional beta3-adrenoceptor in the human heart J Clin Invest 1996, 98:556-62.
23. Brodde OE, Zerkowski HR, Schranz D, Broede-Sitz A, Michel-Reher M, Schafer-Beisenbusch E, Piotrowski JA and Oelert H: Agedependent changes in the β-Adrenoceptor-G Protein(s)-Adenylyl Cyclase system in human right atrium J Cardiovasc Pharmacol 1995, 26:20-6.
24. Brian D Lowes, Wayne Minobe, William T Abraham, Mona N Rizeq, Teresa J Bohlmeyer, Robert A Quaife, Robert L Roden, Darin L Dutcher, Alastair D Robertson, Norbert F Voelkel, David B Badesch, Bertron M Groves, Edward M Gilbert and Michael R Bristow: Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in J Clin Invest 1997, 100:2315-24.